Video

Safety Profile of S1P Receptor Modulators for Multiple Sclerosis

Krzysztof Selmaj, MD, PhD, discusses the side effects of sphinogine-1-phospate (S1P) receptor modulators, highlighting particular adverse events clinicians should be aware of when treating multiple sclerosis (MS).

Related Videos
Kathleen Costello, CRNP, MSCN
Christian Cordano, MD, PhD
Jack P. Antel, M D
Sarah Levy, PhD
Enrique Alvarez, MD, PhD
Ceren Tozlu, PhD
Cristin Welle, PhD
Patricia K. Coyle, MD
© 2025 MJH Life Sciences

All rights reserved.